| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41541-020-00241-Z |
| P698 | PubMed publication ID | 33083032 |
| P50 | author | Hongwei Liu | Q100751554 |
| Christopher Weiss | Q59704591 | ||
| Lark L Coffey | Q89170660 | ||
| Erin Ball | Q92094062 | ||
| P2093 | author name string | Kasen K Riemersma | |
| P2860 | cites work | Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak | Q21144706 |
| Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism | Q21559402 | ||
| Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period | Q21562272 | ||
| Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate | Q24276430 | ||
| Chikungunya, an epidemic arbovirosis | Q24291001 | ||
| Rates of spontaneous mutation among RNA viruses | Q24563020 | ||
| A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection | Q24631774 | ||
| Arbovirus high fidelity variant loses fitness in mosquitoes and mice | Q24635860 | ||
| Viral Polymerase-Helicase Complexes Regulate Replication Fidelity To Overcome Intracellular Nucleotide Depletion | Q24701729 | ||
| DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice | Q24701765 | ||
| Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice | Q24817069 | ||
| IRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cells | Q27486518 | ||
| Infection with chikungunya virus in Italy: an outbreak in a temperate region | Q29346487 | ||
| Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population | Q29616266 | ||
| An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features | Q29620004 | ||
| Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. | Q30145570 | ||
| Epidemiology of Chikungunya in the Americas | Q31147049 | ||
| Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose. | Q33684369 | ||
| Measuring Alphavirus Fidelity Using Non-Infectious Virus Particles | Q95322299 | ||
| Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. | Q33942533 | ||
| Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response | Q34110965 | ||
| Generation and characterization of influenza A viruses with altered polymerase fidelity | Q34137544 | ||
| Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein | Q34264257 | ||
| Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice | Q34394530 | ||
| Host alternation of chikungunya virus increases fitness while restricting population diversity and adaptability to novel selective pressures | Q34485363 | ||
| Chikungunya fever in travelers: clinical presentation and course | Q34580124 | ||
| IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safety | Q34723422 | ||
| A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity | Q35163547 | ||
| High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines | Q35581782 | ||
| IRES-Containing VEEV Vaccine Protects Cynomolgus Macaques from IE Venezuelan Equine Encephalitis Virus Aerosol Challenge | Q35644626 | ||
| DNA replication fidelity | Q35677447 | ||
| IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice | Q37156478 | ||
| Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years. | Q37166091 | ||
| Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing | Q37443100 | ||
| Atypical manifestations of chikungunya infection | Q37588903 | ||
| A novel twelve class fluctuation test reveals higher than expected mutation rates for influenza A viruses | Q38734385 | ||
| Molecular characterization of the 17D-204 yellow fever vaccine | Q40141583 | ||
| A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus | Q40245153 | ||
| Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study | Q40318152 | ||
| A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years | Q40372969 | ||
| Generation of a Genetically Stable High-Fidelity Influenza Vaccine Strain | Q40385326 | ||
| Deep sequencing analysis of viral infection and evolution allows rapid and detailed characterization of viral mutant spectrum | Q41378628 | ||
| Current status of dengue and chikungunya in India | Q43039609 | ||
| Neurologic manifestations of pediatric chikungunya infection | Q44140290 | ||
| Isolation of the vaccine strain of Venezuelan equine encephalomyelitis virus from mosquitoes in Louisiana | Q44157061 | ||
| Attenuated Mutants of Venezuelan Equine Encephalitis Virus Containing Lethal Mutations in the PE2 Cleavage Signal Combined with a Second-Site Suppressor Mutation in E1 | Q44169045 | ||
| Development of an attenuated strain of chikungunya virus for use in vaccine production | Q44523303 | ||
| Neurological complications of Chikungunya virus infection | Q44850725 | ||
| Engineering attenuated virus vaccines by controlling replication fidelity | Q45397402 | ||
| Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone | Q45852646 | ||
| Acute inflammatory arthritis: Long-term effects of chikungunya | Q49838689 | ||
| [Neurological manifestations in Chikungunya: about 23 cases collected in Reunion Island]. | Q52589569 | ||
| Low-fidelity Venezuelan equine encephalitis virus polymerase mutants to improve live-attenuated vaccine safety and efficacy. | Q54246382 | ||
| Vector competence of Aedes aegypti, Culex tarsalis, and Culex quinquefasciatus from California for Zika virus. | Q55496556 | ||
| Analysis By Deep Sequencing of Discontinued Neurotropic Yellow Fever Vaccine Strains | Q57028613 | ||
| Defining a correlate of protection for chikungunya virus vaccines | Q59350720 | ||
| An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar | Q60916834 | ||
| Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence | Q93208166 | ||
| P921 | main subject | chikungunya | Q243257 |
| attenuated vaccine | Q1810913 | ||
| Chikungunya virus | Q15794049 | ||
| P304 | page(s) | 97 | |
| P577 | publication date | 2020-10-14 | |
| P1433 | published in | NPJ Vaccines | Q30275609 |
| P1476 | title | Engineering a fidelity-variant live-attenuated vaccine for chikungunya virus | |
| P478 | volume | 5 |
Search more.